Lipid metabolism pathway enzyme

The term "Lipid metabolism pathway enzymes" refers to a broad group of enzymes involved in the regulation, synthesis, breakdown, and remodeling of lipids within cells. These include key molecules such as HMG-CoA reductase, fatty acid synthase, acetyl-CoA carboxylase, and others that play essential roles in energy storage/utilization, cell membrane structure maintenance, and signaling. Dysregulation or reprogramming of these pathways is implicated in diseases such as cancer—where altered lipid metabolism supports tumor growth—and neurodegenerative disorders like Alzheimer’s disease—where genes affecting lipid handling are risk factors for pathology[1][2]. While individual enzymes within this pathway are considered therapeutic targets with drugs developed against them (e.g., statins), the phrase itself does not refer to a single molecular entity but rather an entire class or network. Therefore, it is not appropriate as a canonical target name; more specificity is needed to identify actionable drug targets. Notes on correctness/structure: The entry "Lipid metabolism pathway enzymes" is too broad and non-specific for use as a canonical target name. It refers collectively to many different proteins rather than one defined molecular entity. For structured data purposes or drug discovery targeting efforts, it would be necessary to specify which enzyme(s) within the lipid metabolic pathways are being referenced—such as "Fatty acid synthase," "HMG-CoA reductase," etc.—to provide meaningful information about mechanism-of-action or clinical relevance[1][2].

Inhibition of cholesterol biosynthesis enzymes[1]